Type / Class
Equity / Ordinary Shares, par value NIS 1.50 per share (including Ordinary Shares represented by American Depositary Shares at a 1-to-1 ratio)
Shares outstanding
12,690,589
Total 13F shares
628,916
Share change
+466,518
Total reported value
$6,282,000
Price per share
$9.99
Number of holders
6
Value change
+$4,662,790
Number of buys
5
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 19516R107?
CUSIP 19516R107 identifies CLGN - Collplant Biotechnologies Ltd. - Ordinary Shares, par value NIS 1.50 per share (including Ordinary Shares represented by American Depositary Shares at a 1-to-1 ratio) in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Collplant Biotechnologies Ltd. - Ordinary Shares, par value NIS 1.50 per share (including Ordinary Shares represented by American Depositary Shares at a 1-to-1 ratio) (CLGN) as of Q2 2020

As of 30 Jun 2020, Collplant Biotechnologies Ltd. - Ordinary Shares, par value NIS 1.50 per share (including Ordinary Shares represented by American Depositary Shares at a 1-to-1 ratio) (CLGN) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 628,916 shares. The largest 6 holders included MEITAV DASH INVESTMENTS LTD, INVESTMENT MANAGEMENT OF VIRGINIA LLC, VILLERE ST DENIS J & CO LLC, RENAISSANCE TECHNOLOGIES LLC, ROYAL BANK OF CANADA, and UBS Group AG. This page lists 6 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.